Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2

BACKGROUND: The antigenicity of SARS‐CoV‐2 is a critical issue for the effectiveness of the vaccine, and thus, it should be phenotypically evaluated by serological assays as new field isolates emerge. The hemagglutination/hemagglutination inhibition (HA/HI) tests are well known as a representative m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Jun, Matsuyama, Shutoku, Shirakura, Masayuki, Arita, Tomoko, Suzuki, Yasushi, Asanuma, Hideki, Watanabe, Shinji, Hasegawa, Hideki, Nakamura, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942275/
https://www.ncbi.nlm.nih.gov/pubmed/36824396
http://dx.doi.org/10.1111/irv.13093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942275/
https://www.ncbi.nlm.nih.gov/pubmed/36824396
http://dx.doi.org/10.1111/irv.13093

Ejemplares similares